We did not collect information regarding tumor grade for the remaining eleven women who had stage 1 breast cancer, and therefore, it is possible that the lack of variability and the absence of high-grade tumors in our small cohort is the reason why we did not observe a decrease in Ki-67 after statin treatment. Here, MKI67 is linked to breast cancer.